✦ LIBER ✦

Preclinical Evaluation of Two Human Anti–Hepatitis B Virus (HBV) Monoclonal Antibodies in the HBV-Trimera Mouse Model and in HBV Chronic Carrier Chimpanzees

✍ Scribed by Rachel Eren; Ehud Ilan; Ofer Nussbaum; Ido Lubin; Dov Terkieltaub; Yossi Arazi; Ofer Ben-Moshe; Alberto Kitchinzky; Shoshana Berr; Judy Gopher; Arie Zauberman; Eithan Galun; Danny Shouval; Nili Daudi; Ahamed Eid; Oded Jurim; Lars O. Magnius; Berit Hammas; Yair Reisner; Shlomo Dagan

Book ID: 111721324
Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 323 KB
Volume: 32
Category: Article
ISSN: 0270-9139
DOI: 10.1053/jhep.2000.9632

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The hepatitis B virus–trimera mouse: A m

The hepatitis B virus–trimera mouse: A model for human HBV infection and evaluation of anti-HBV therapeutic agents

✍ Ehud Ilan; Tatjana Burakova; Shlomo Dagan; Ofer Nussbaum; Ido Lubin; Rachel Eren 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

Previous studies have demonstrated the feasibility of implantation of human blood cells or tissues in lethally irradiated mice or rats, radioprotected with SCID mouse bone marrow cells: The Trimera system. In the present study, we describe the development of a mouse Trimera model for human hepatitis

Induction of strong hepatitis B virus (H

Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection

✍ Wulf O. Böcher; Benjamin Dekel; Wibke Schwerin; Michael Geissler; Sina Hoffmann; 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 142 KB 👁 2 views

Reduced hepatitis B virus surface antige

Reduced hepatitis B virus surface antigen–specific Th1 helper cell frequency of chronic HBV carriers is associated with a failure to produce antigen-specific antibodies in the Trimera mouse

✍ Wulf Otto Böcher; Eithan Galun; Hadar Marcus; Nili Daudi; Dov Terkieltaub; Danie 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

1144 A phase 2 clinical study evaluating

1144 A phase 2 clinical study evaluating safety and efficacy of Hepex-B, a mixture of two human monoclonal antibodies to HBsAg in combination with lamivudine in chronic HBV patients

✍ GALUN, E; SAFADI, R; MILCHEM, A; AKERMAN, Z; ASHUR, Y; MATHOT, I; YOUNOSSI, Z; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

95 Preclinical evaluation of two human a

95 Preclinical evaluation of two human anti-HBV monoclonal antibodies in two animal models for HBV infection : E. Ilan1, R. Eren1, O. Nussbaum1, I. Lubin1, D. Terkieltaub1, O. BenMoshe1, Y. Arazi1, S. Berr1, J. Gopher J1, A. Kitchinzky1, D. Shouval2, E. Galun2, Y. Reisner3 and S. Dagan1. XTL Biopharmaceuticals, Kiryat Weizmann, Rehovot1, Hadassah University Hospital, Jerusalem2 and the Weizmann Institute of Science3, Rehovot, ISRAEL

📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 126 KB

Use of a filter binding sample preparati

Use of a filter binding sample preparation method for the PCR detection of hepatitis B virus (HBV) in cell culture or in human sera and for the demonstration of the anti-HBV activity of two halogenated pyrimidine nucleoside analogs : 1K. A. Staschke, 1J. M. Colacino, and 2C.-H. Lee. 1Lilly Research Laboratories and 2Indiana University School of Medicine, Indianapolis, Indiana, USA

📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 53 KB